| Original language | English |
|---|---|
| Pages (from-to) | 432-434 |
| Number of pages | 3 |
| Journal | Journal of Clinical Neurology (Korea) |
| Volume | 13 |
| Issue number | 4 |
| DOIs | |
| State | Published - Oct 2017 |
Bibliographical note
Funding Information:H.-J.B. is involved as the principal investigator, a member of the steering committee, and site investigator of multicenter clinical trials and clinical studies sponsored by Otsuka Korea, Bayer Korea, Boehringer Ingelheim Korea, Handok Pharmaceutical Company, SK Chemicals, Pfizer, ESAI-Korea, Daewoong Pharmaceutical, Daichi Sankyo, AstraZeneca Korea, Dong-A Pharmaceutical, and Yuhan Corporation. H.-J.B. has served on the scientific advisory boards for Bayer Korea, Boehringer Ingelheim Korea, BMS Korea, and Pfizer Korea; served as a consultant for YuYu Pharmaceutical, Daewoong Pharmaceutical and Korean Drug and received modest lecture honoraria from AstraZeneca Korea, Bayer Korea, BMS Korea, Coviden Korea, Esai Korea, Daichi Sankyo Korea, and Sanofi-Aventis Korea.